Roche Holding stock before the bell after a 0.8 percent slip

At the close on September 10, 2026, Roche Holding stock fell 0.8 percent to CHF 344.80 on the SIX Swiss Exchange. The share traded between CHF 343.10 and CHF 350.00, while the SMI stood at 13,803 points in midday trading.

Roche Holding stock closed at CHF 344.80 on the SIX Swiss Exchange on September 10, 2026, down 0.8 percent. The session moved between CHF 343.10 and CHF 350.00, with the SMI at 13,803 points around midday.

September 10, 2026 in numbers

Roche Holding AG (ISIN CH0012032048) opened at CHF 350.00 and finished below that level after a quiet Zurich session. The close also left the shares under the CHF 356.20 level from the prior session, according to ad hoc news, which tied the move to Roche's FDA Priority Review announcement for Enspryng in MOGAD. Morningstar listed the stock's 52-week range at CHF 252.20 to CHF 375.80 and put the market value at CHF 275.28 billion.

Today ahead of the open

Roche announced on September 10, 2026 that the U.S. Food and Drug Administration granted Priority Review for Enspryng in MOGAD, a regulatory step that can keep attention on the shares today, according to Roche. The company also appears in Yahoo Finance's earnings calendar for September 11, 2026, and Swiss investors will also track the broader European risk tone after Thursday's firmer session in regional equities.